| MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia A Navinés-Ferrer, E Serrano-Candelas, A Lafuente, R Muñoz-Cano, ... Scientific reports 8 (1), 11628, 2018 | 153 | 2018 |
| IgE‐related chronic diseases and anti‐IgE‐based treatments A Navinés-Ferrer, E Serrano-Candelas, GJ Molina-Molina, M Martín Journal of immunology research 2016 (1), 8163803, 2016 | 126 | 2016 |
| Long-tailed unconventional class I myosins in health and disease A Navinés-Ferrer, M Martín International Journal of Molecular Sciences 21 (7), 2555, 2020 | 27 | 2020 |
| Silencing of adaptor protein SH 3 BP 2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth E Serrano‐Candelas, E Ainsua‐Enrich, A Navinés‐Ferrer, P Rodrigues, ... Molecular Oncology 12 (8), 1383-1397, 2018 | 20 | 2018 |
| Mutation in KARS: A novel mechanism for severe anaphylaxis P Ribó, Y Guo, J Aranda, E Ainsua-Enrich, A Navinés-Ferrer, M Guerrero, ... Journal of Allergy and Clinical Immunology 147 (5), 1855-1864. e9, 2021 | 17 | 2021 |
| Efficient correction of Abca4 variants by CRISPR-Cas9 in hiPSCs derived from stargardt disease patients L Siles, S Ruiz-Nogales, A Navinés-Ferrer, P Méndez-Vendrell, ... Molecular Therapy-Nucleic Acids 32, 64-79, 2023 | 12 | 2023 |
| The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth E Proaño-Pérez, E Serrano-Candelas, A García-Valverde, J Rosell, ... Cancer Gene Therapy 30 (2), 245-255, 2023 | 11 | 2023 |
| MYO1F regulates IgE and MRGPRX2-dependent mast cell exocytosis A Navinés-Ferrer, E Ainsua-Enrich, E Serrano-Candelas, E Proaño-Pérez, ... The Journal of Immunology 206 (10), 2277-2289, 2021 | 11 | 2021 |
| Myo1f, an unconventional long-tailed myosin, is a new partner for the adaptor 3BP2 involved in mast cell migration A Navinés-Ferrer, E Ainsua-Enrich, E Serrano-Candelas, J Sayós, ... Frontiers in immunology 10, 1058, 2019 | 9 | 2019 |
| SH3BP2 silencing increases miRNAs Targeting ETV1 and microphthalmia-associated transcription factor, decreasing the proliferation of gastrointestinal stromal tumors E Proaño-Pérez, E Serrano-Candelas, C Mancia, A Navinés-Ferrer, ... Cancers 14 (24), 6198, 2022 | 8 | 2022 |
| Impaired bestrophin channel activity in an iPSC-RPE model of best vitelliform macular dystrophy (BVMD) from an early onset patient carrying the P77S dominant mutation A Navinés-Ferrer, S Ruiz-Nogales, R Navarro, E Pomares International Journal of Molecular Sciences 23 (13), 7432, 2022 | 4 | 2022 |
| Author Correction: MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia A Navinés-Ferrer, E Serrano-Candelas, A Lafuente, R Muñoz-Cano, ... Scientific Reports 11, 2021 | 1 | 2021 |
| Gene editing for inherited retinal dystrophies: precise correction of pathogenic variants and optimization of the assay design L Siles, S Ruiz-Nogales, P Mendez, P Gaudo, A Navines-Ferrer, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 306-307, 2024 | | 2024 |
| 3 different iPSC-derived cell models for the study of Stargardt Disease and Retinitis Pigmentosa A Navines-Ferrer, P Mendez, L Siles, P Gaudo, E Pomares EUROPEAN JOURNAL OF HUMAN GENETICS 32, 113-114, 2024 | | 2024 |
| Generation of retinal models from two iPSC lines derived from patients harboring mutations in PDE6A and PDE6C genes. PG Pardo, A Navinés-Ferrer, PM Vendrell, L Siles, E Pomares Investigative Ophthalmology & Visual Science 64 (8), 3195-3195, 2023 | | 2023 |
| High efficiency in genome editing of pathogenic variants causing Inherited Retinal Dystrophies: the importance of CRISPR/TALEN guides and repair templates designs L Siles, S Ruiz-Nogales, A Navinés-Ferrer, PG Pardo, E Pomares Investigative Ophthalmology & Visual Science 64 (8), 759-759, 2023 | | 2023 |
| Correction to: The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth E Proaño-Pérez, E Serrano-Candelas, A García-Valverde, J Rosell, ... Cancer gene therapy 30 (2), 388, 2023 | | 2023 |
| Correction: MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis A Navinés-Ferrer, E Ainsua-Enrich, E Serrano-Candelas, E Proaño-Pérez, ... The Journal of Immunology 207 (11), 2894-2894, 2021 | | 2021 |
| MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia (vol 8, 11628, 2018) A Navines-Ferrer, E Serrano-Candelas, A Lafuente, R Munoz-Cano, ... SCIENTIFIC REPORTS 11 (1), 2021 | | 2021 |
| The adaptor 3BP2 is required for human mast cell migration and survival M Martin, E Ainsua-Enrich, E Serrano-Candelas, A Navines-Ferrer, ... ALLERGY 70, 72-72, 2015 | | 2015 |
